Back to Agenda
New European Clinical Trial Regulation: A New Paradigm with Major Impact on Clinical Trial Stakeholders
Session Chair(s)
Elke Stahl, PHD
Senior Expert, Clinical Trials Department, Federal Institute For Drugs and Medical Devices (BfArM), Germany
Are stakeholders ready for implementation of the EU Clinical Trial Regulation? Challenges, expectations and progress will be updated by Members States and sponsors.
Speaker(s)
Greet Musch, PHD
strategic adviser , FAMHP, Belgium
The Implementation of the Clinical Trial Regulation at Member State Level: The State of Play in Belgium
Thorsten Ruppert, PHARMD
Senior Manager Research/Development/Innovation, vfa - German Association of Research-Based Pharmaceutical Companies, Germany
Is Industry Prepared? Experiences from the German Pilot as an Example for Challenges for Industry
Anastassia Negrouk
Head of International Policy Office, DPO, EORTC, Belgium
Key Aspects to Consider to Ensure CTR Implementation Positively Impacts Non-For-Profit Clinical Research
Have an account?